Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523897 · ClinicalTrials.gov registry record · NA
A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes
A NA study, sponsored by Virtua Health.
- Terminated
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT03523897: Clinical Trial NA study, sponsored by Virtua Health.
NCT03523897 is a NA study that was terminated before completion, run by Virtua Health. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03523897, a NA study, was terminated before completion, sponsored by Virtua Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
This study aims to see if outcomes for patients that receive the traditional total knee replacement surgical technique are different than the outcomes for patients that receive robot-assisted total knee replacement. The outcomes we will be tracking include: 1. Patients' self-reported awareness of their artificial joints during activities of daily living; 2. Patient's self-reported pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life; 3. Patients' self-reported general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy-fatigue, social functioning and mental health; 4. The accuracy of implant placement and limb alignment
Primary Outcome
The FJS is a self-completed 12-item questionnaire used to assess patients' awareness of their artificial joint during activities of daily living on an awareness scale of 0 (never) to 4 (mostly)
Interventions
- PROCEDURE Robot Assisted Total Knee Replacement
- PROCEDURE Traditional Total Knee Replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-04-20 |
| Est. Completion | 2022-07-14 |
| Phase | NA |
Why NCT03523897 stopped before completion
NCT03523897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Robot Assisted Total Knee Replacement is the first listed.
NCT03523897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03523897 about?
NCT03523897 is a clinical study titled "A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes". This study aims to see if outcomes for patients that receive the traditional total knee replacement surgical technique are different than the outcomes for patients that receive robot-assisted total knee replacement. The outcomes we will be tracking include: 1. Patients' self-reported awareness of t...
What is the current status of trial NCT03523897?
This trial is currently terminated. It is a NA study. The enrollment target is 92 participants. The study started on 2018-04-20. Estimated completion is 2022-07-14.
What interventions are being tested in trial NCT03523897?
The interventions under investigation include: Robot Assisted Total Knee Replacement (PROCEDURE), Traditional Total Knee Replacement (PROCEDURE).
Who is sponsoring clinical trial NCT03523897?
This trial is sponsored by Virtua Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03523897's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI